The Sleep Apnea Devices Market size was estimated to be US$ 6280.09 million in 2023 and is expected to reach US$ 12,987.44 million by 2031; it is estimated to record a CAGR of 7.7% in 2031. The increasing prevalence of respiratory diseases, sedentary lifestyle, increasing aging population (over 60 years), and growing prevalence of chronic disorders is likely to remain key Sleep Apnea Devices Market trends.

Sleep Apnea Devices Market Analysis

Increasing life expectancy across the globe is likely to increase the prevalence of sleep disorders. The study ‘Global Prevalence of Obstructive Sleep Apnea in the Elderly and Related Factors: A Systematic Review and Meta-Analysis Study,’ published in June 2023, aimed to combine data and statistics on the worldwide prevalence of OSA in the elderly population. It combined data from 39 studies with a total sample size of 33,353 people were included. The pooled prevalence of OSA in the elderly population was 35.9% (95% confidence interval: 28.7%-43.8%; I2 = 98.81%). The above-mentioned factor is anticipated to have a positive impact on the growth of the sleep apnea devices market.

Sleep Apnea Devices Market Overview

The growth of the sleep apnea devices market is attributed to some key driving factors such as the increasing prevalence of respiratory diseases, sedentary lifestyle, increasing aging population (over 60 years), and rising prevalence of chronic disorders. However, leaky masks and trouble in falling asleep are major factors hindering the market growth. Global sleep apnea devices market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. In North America, the US is the largest market for sleep apnea devices. The growth of the region is attributed to the presence of key market players and rising prevalence of the geriatric population. In addition, continuous product developments are further expected to stimulate the growth of the sleep apnea devices market in North America.

The Asia Pacific region is expected to account for the fastest growth in the sleep apnea devices market. The sleep apnea devices market in the Asia Pacific is likely to witness rapid growth owing to a large population, rising medical tourism, and availability of cost-effective sleep apnea devices.  Such a factor is expected to aid the growth of the sleep apnea devices market during the forecast period.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Sleep Apnea Devices Market: Strategic Insights

Sleep Apnea Devices Market

• 
  CAGR (2023 - 2031)

  7.7%
• Market Size 2023
  US$ 6280.09 million
• Market Size 2031
  US$ 12987.44 million

Market Dynamics

GROWTH DRIVERS

• Increasing life expectancy across the globe is likely to increase the prevalence of sleep disorders. The study ‘Global Prevalence of Obstructive Sleep Apnea in the Elderly and Related Factors: A Systematic Review and Meta-Analysis Study,’ published in June 2023, aimed to combine data and statistics on the worldwide prevalence of OSA in the elderly population. It combined data from 39 studies with a total sample size of 33,353 people were included. The pooled prevalence of OSA in the elderly population was 35.9% (95% confidence interval: 28.7%-43.8%; I2 = 98.81%). The above-mentioned factor is anticipated to have a positive impact on the growth of sleep apnea devices market

FUTURE TRENDS

• Cardiovascular disease refers to the following 4 entities i.e., coronary artery disease (CAD) which is also referred to as coronary heart disease (CHD), cerebrovascular disease, peripheral artery disease (PAD), and aortic atherosclerosis. According to the National Institute of Health (NIH), an estimated 16.3 million Americans aged 20 and older have CHD, a prevalence of 7 percent. The prevalence for men is 8.3 percent and for women is 6.1 percent. Continuous PAP (CPAP) is the common treatment for patients with moderate to severe OSA (AHI ? 15 events/h) in the absence of symptoms, but it is also recommended for the treatment of mild OSA patients (AHI 5-15 events/h) in the presence of EDS or other comorbidities such as obesity, hypertension, and cardiac arrest. This need is likely to drive the sleep apnea devices market during the forecast period

OPPORTUNITIES

• Obstructive sleep apnea (OSA) is a normal and very common disorder categorized by the upper airway's repetitive, complete, or partial closure. In contrast, sleep is helpful in the fragmentation of sleep and oxygen desaturation. The disorder causes significant morbidity, especially in terms of impairment of daytime functioning and the impact this has on quality of life. The recent indication from the controlled trials is proof that oral appliance therapy is very effective in controlling OSA in up to 50.0% of patients, including some patients with more severe forms of OSA. This is associated with a significant improvement in symptoms, including snoring and daytime sleepiness. This evidence is strong for short-term and emerging long-term treatment of OSA with oral appliances. Various companies have developed their products for treating sleep apnea and related accessories. For instance, SomnoDent devices developed by SomnoMed Limited have increased in the previous year, 2016, from 68% to 68.6%, which signifies that the products have achieved the signature line of products. Additionally, SomnoDent Alpha has developed and received FDA approval in September 2016. The Alpha is an instant fit device used in sleep clinics for offering the patient and delivering efficacy data of a continuous open airway therapy (COAT) treatment relating to a specific patient before a device is custom-made for the patient. In February 2024, ResMed launched its AirCurve 11 series which are the bilevel devices that use two levels of support, inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP). The AirCurve 11 series is combined with digital tech to help treat sleep apnea. Such technological advancements are estimated to generate attractive growth opportunity for the sleep apnea devices market

Key Players

• Resmed
• Koninklijke Philips N.V.
• Fisher & Paykel
• Braebon Medical Corporation
• Compumedics Limited
• BMC Medical Co., Ltd
• SomnoMed Limited
• Weinmann Emergency Medical Technology GmbH + CO. KG
• Devilbiss Healthcare LLC
• Cadwell Industries, Inc.

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Diagnostic Devices

• Polysomnography Devices
• Respiratory Polygraphs
• Actigraphy Systems
• Single-Channel Screening Devices

Therapeutic Devices [Facial Interfaces, Adaptive Servo-Ventilation Instruments

• ASV
• Positive Airway Pressure

End User

• Home Healthcare
• Sleep Laboratories
• Hospitals

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Sleep Apnea Devices Market Drivers and Opportunities

Rising Prevalence of Cardiovascular Diseases to Favor Market

Cardiovascular disease refers to the following 4 entities i.e., coronary artery disease (CAD) which is also referred to as coronary heart disease (CHD), cerebrovascular disease, peripheral artery disease (PAD), and aortic atherosclerosis. According to the National Institute of Health (NIH), an estimated 16.3 million Americans aged 20 and older have CHD, a prevalence of 7 percent. The prevalence for men is 8.3 percent and for women is 6.1 percent. Continuous PAP (CPAP) is the common treatment for patients with moderate to severe OSA (AHI ≥ 15 events/h) in the absence of symptoms, but it is also recommended for the treatment of mild OSA patients (AHI 5-15 events/h) in the presence of EDS or other comorbidities such as obesity, hypertension, and cardiac arrest. This need is likely to drive the sleep apnea devices market during the forecast period.

Technological developments – An Opportunity in Sleep Apnea Devices Market

Obstructive sleep apnea (OSA) is a normal and very common disorder categorized by the upper airway's repetitive, complete, or partial closure. In contrast, sleep is helpful in the fragmentation of sleep and oxygen desaturation. The disorder causes significant morbidity, especially in terms of impairment of daytime functioning and the impact this has on quality of life. The recent indication from the controlled trials is proof that oral appliance therapy is very effective in controlling OSA in up to 50.0% of patients, including some patients with more severe forms of OSA. This is associated with a significant improvement in symptoms, including snoring and daytime sleepiness. This evidence is strong for short-term and emerging long-term treatment of OSA with oral appliances. Various companies have developed their products for treating sleep apnea and related accessories. For instance, SomnoDent devices developed by SomnoMed Limited have increased in the previous year, 2016, from 68% to 68.6%, which signifies that the products have achieved the signature line of products. Additionally, SomnoDent Alpha has developed and received FDA approval in September 2016. The Alpha is an instant fit device used in sleep clinics for offering the patient and delivering efficacy data of a continuous open airway therapy (COAT) treatment relating to a specific patient before a device is custom-made for the patient. In February 2024, ResMed launched its AirCurve 11 series which are the bilevel devices that use two levels of support, inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP). The AirCurve 11 series is combined with digital tech to help treat sleep apnea. Such technological advancements are estimated to generate attractive growth opportunity for the sleep apnea devices market.

Sleep Apnea Devices Market Report Segmentation Analysis

Key segments that contributed to the derivation of the Sleep Apnea Devices Market analysis are diagnostic devices and end user.

• Based on diagnostic devices, the sleep apnea diagnostic devices market is segmented into polysomnography devices, respiratory polygraphs, actigraphy systems, and oximeters. The market for sleep apnea is majorly driven by polysomnography devices, as these are more advanced and specialized devices than others.
• The global sleep apnea market, based on the end-user, was segmented into home healthcare, and sleep laboratories & hospitals. In 2023, the home healthcare segment held the largest share of the market by end user. In addition, the segment is also expected to grow at the fastest rate during the coming years owing to the advantages of the home healthcare segments. Home healthcare services are similar to skilled nursing facilities and hospitals available to treat patients at home. These facilities are used to treat injuries and diseases with more convenience and less cost. This service helps patients treat their sicknesses and injuries and helps them be self-sufficient to regain their independence. The patients feel more comfortable and relaxed in their own houses and respond well to the treatment.

Sleep Apnea Devices Market Share Analysis by Geography

The geographic scope of the Sleep Apnea Devices Market report is mainly divided into five regions: North America, Asia Pacific, Europe, the Middle East & Africa, and South America/South & Central America.

In terms of revenue, North America dominated the sleep apnea devices market share. The North America sleep apnea devices market has been segmented into the US, Canada, and Mexico. The US holds the largest share of the North American sleep apnea devices market. Increasing prevalence of sleep apnea disorders among the American population is one of the key factors increasing the demand for sleep apnea devices, thus driving the  growth of North America market.   Further, high prevalence of sleep apnea and rising awareness about sleep disorders and its risk factors in the US is likely to drive the US sleep apnea devices market. As per the Centers for Disease Control and Prevention (CDC), around one third of the US Population gets less than required amount of sleep. Additionally, as per the American Sleep Apnea Association, around 22 million Americans suffer from sleep apnea. Thus, the growing prevalence of sleep apnea will likely contribute to the growth of the US sleep apnea devices market size.

Sleep Apnea Devices Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Sleep Apnea Devices Market News and Recent Developments

The Sleep Apnea Devices Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for Sleep Apnea Devices and strategies:

• Evora Full – a compact full-face mask for sleep apnea has a floating seal and stability wings that work together to create the next generation of Dynamic Support Technology. The compact seal floats under the nose to provide patients with a clear line of sight, while stability wings keep the seal stable. (Source: Fisher & Paykel Healthcare, Corporate News, 2022)

Sleep Apnea Devices Market Report Coverage and Deliverables

The “Sleep Apnea Devices Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Market dynamics such as drivers, restraints, and key opportunities
• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
• Detailed company profiles